Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DAPT(Dual Antiplatelet Therapy)”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07164859
What this trial is testing

Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

Who this might be right for
Coronary Artery Disease (CAD)Percutaneous Coronary Intervention (PCI)Antiplatelet Therapy+1 more
Vincent ROULE 1,700
Not applicableStudy completedNCT03197298
What this trial is testing

Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromePercutaneous Coronary InterventionDrug-Eluting Stents
Thorax Centrum Twente 2,062
Post-approval studies (Phase 4)UnknownNCT04116931
What this trial is testing

OPTImal Management of Antithrombotic Agents: OPTIMA-5

Who this might be right for
Acute Coronary Syndrome (ACS)
The First Affiliated Hospital with Nanjing Medical University 80
Not applicableNot Yet RecruitingNCT05650411
What this trial is testing

Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)

Who this might be right for
Left Main Coronary Artery Stenosis
IGLESIAS Juan Fernando 828
Post-approval studies (Phase 4)Study completedNCT01995370
What this trial is testing

Cilostazol Stroke Prevention Study for Antiplatelet Combination

Who this might be right for
Noncardioembolic Cerebral Infarction
Japan Cardiovascular Research Foundation 1,884
Not applicableLooking for participantsNCT05785897
What this trial is testing

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

Who this might be right for
ST Elevation Myocardial Infarction
IGLESIAS Juan Fernando 350
Post-approval studies (Phase 4)Not Yet RecruitingNCT07007143
What this trial is testing

STrategies for AntithRombotic Treatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant

Who this might be right for
Mitral Regurgitation
Chinese Academy of Medical Sciences, Fuwai Hospital 1,032
Post-approval studies (Phase 4)Study completedNCT01106534
What this trial is testing

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort

Who this might be right for
Chronic Total Occlusion of Coronary ArteryVascular DiseaseMyocardial Ischemia+4 more
Abbott Medical Devices 870
Post-approval studies (Phase 4)Looking for participantsNCT07111559
What this trial is testing

Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

Who this might be right for
Lacunar StrokeStrokeIschemic Stroke
Nippon Medical School 500
Not applicableUnknownNCT03338335
What this trial is testing

Ethnic Differences and the Ischemia/Bleeding Risk of DAPT Duration

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionDual Antiplatelet Therapy
Seoul National University Hospital 16,000
Post-approval studies (Phase 4)Study completedNCT04006288
What this trial is testing

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
University of Florida 90
Not applicableNot Yet RecruitingNCT07354828
What this trial is testing

Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy

Who this might be right for
Acute Coronary Syndrome (ACS)High Bleeding Risk (HBR)Coronary Artery Disease (CAD)
Shenyang Northern Hospital 3,500
Post-approval studies (Phase 4)Looking for participantsNCT06007222
What this trial is testing

Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

Who this might be right for
Aortic StenosisTAVI(Transcatheter Aortic Valve Implantation)Aspirin+2 more
OCEAN-SHD Study Group 400
Not applicableStudy completedNCT05750758
What this trial is testing

Rivaroxaban Combined With DAPT Versus DAPT Alone After Drug-coated Balloon Angioplasty

Who this might be right for
Acute Coronary Syndrome
Henan Institute of Cardiovascular Epidemiology 140
Post-approval studies (Phase 4)Looking for participantsNCT06821191
What this trial is testing

Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

Who this might be right for
Coronary Artery Disease
University of Florida 78
Post-approval studies (Phase 4)Not Yet RecruitingNCT06763744
What this trial is testing

Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR

Who this might be right for
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)High Bleeding Risk
Samsung Medical Center 3,000
Not applicableStudy completedNCT03355742
What this trial is testing

XIENCE 28 Global Study

Who this might be right for
Bleeding DisorderStroke, IschemicStroke Hemorrhagic+6 more
Abbott Medical Devices 963
Post-approval studies (Phase 4)Active Not RecruitingNCT05631769
What this trial is testing

HOST - DAPT Duration According the Bleeding Risk

Who this might be right for
Coronary Artery DiseaseAcute Myocardial InfarctionStable Angina
Seoul National University Hospital 4,900
Not applicableLooking for participantsNCT07039149
What this trial is testing

Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents

Who this might be right for
Major BleedingMajor Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Jordan Collaborating Cardiology Group 200
Not applicableStudy completedNCT05487560
What this trial is testing

An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding

Who this might be right for
Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months
Hanmi Pharmaceutical Company Limited 4,133
Load More Results